Aarti Pharmalabs Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|
| Revenue | 380.24 | 395.60 | 420.50 |
| Operating Expense | 292.52 | 309.83 | 307.47 |
| Net Profit | 47.84 | 47.14 | 63.02 |
| Net Profit Margin | 12.58 | 11.92 | 14.99 |
| Earning Per Share | 5.28 | 5.20 | 6.95 |
| EBIDTA | 84.91 | 81.25 | 96.46 |
| Effective Tax Rate | 14.58 | 13.49 | 10.35 |
| Particulars | Sep 2024 |
|---|---|
| Revenue | 380.24 |
| Operating Expense | 292.52 |
| Net Profit | 47.84 |
| Net Profit Margin | 12.58 |
| Earning Per Share | 5.28 |
| EBIDTA | 84.91 |
| Effective Tax Rate | 14.58 |
Invest in Aarti Pharmalabs Ltd
₹0 Brokerage*
Open Demat Account
*By signing up you agree to our Terms and Conditions
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Total Revenue Annual | 1,502.13 | 1,511.25 | 941.02 |
| Operating Expenses Annual | 1,155.97 | 1,202.91 | 761.24 |
| Operating Profit Annual | 357.17 | 309.62 | 182.30 |
| Interest Annual | 16.63 | 20.49 | 11.34 |
| Depreciation | 64.74 | 55.73 | 37.23 |
| Net Profit Annual | 200.65 | 171.73 | 106.73 |
| Tax Annual | 73.87 | 61.63 | 27 |
| Particulars | Mar 2024 |
|---|---|
| Total Revenue Annual | 1,502.13 |
| Operating Expenses Annual | 1,155.97 |
| Operating Profit Annual | 357.17 |
| Interest Annual | 16.63 |
| Depreciation | 64.74 |
| Net Profit Annual | 200.65 |
| Tax Annual | 73.87 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Cash Flow at the Beginning | 0.30 | 56.50 | 0.25 |
| Cash Flow from Operations | 183.69 | 215.88 | -64.84 |
| Cash Flow from Investing | -184.40 | -115.55 | -133.54 |
| Cash Flow from Financing | 4.40 | -156.53 | 254.63 |
| Cash Flow at the End | 4 | 0.30 | 56.50 |
| Particulars | Mar 2024 |
|---|---|
| Cash Flow at the Beginning | 0.30 |
| Cash Flow from Operations | 183.69 |
| Cash Flow from Investing | -184.40 |
| Cash Flow from Financing | 4.40 |
| Cash Flow at the End | 4 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| PBDIT Margin (%) | 23.78 | 20.49 | 19.37 |
| PBIT Margin (%) | 19.38 | 16.80 | 15.42 |
| PBT Margin (%) | 18.21 | 15.98 | 14.06 |
| Net PROFIT Margin (%) | 13.36 | 11.36 | 11.34 |
| Return On Networth / Equity (%) | 13.11 | 12.61 | 16.62 |
| Return On Networth /Employed (%) | 16.40 | 15.56 | 18 |
| Return On Assets (%) | 11.35 | 10.57 | 13.27 |
| Total Debt / Equity (X) | 0.16 | 0.20 | 0.25 |
| Asset Turnover Ratio (%) | 0.85 | 0.93 | 1.17 |
| Particulars | Mar 2024 |
|---|---|
| PBDIT Margin (%) | 23.78 |
| PBIT Margin (%) | 19.38 |
| PBT Margin (%) | 18.21 |
| Net PROFIT Margin (%) | 13.36 |
| Return On Networth / Equity (%) | 13.11 |
| Return On Networth /Employed (%) | 16.40 |
| Return On Assets (%) | 11.35 |
| Total Debt / Equity (X) | 0.16 |
| Asset Turnover Ratio (%) | 0.85 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Fixed Assets Annual | 1,011.75 | 888.06 | 723.26 |
| Total Current Assets Annual | 1,134.06 | 966.22 | 890.27 |
| Non Current Assets Annual | 1,162.85 | 1,010.15 | 936.56 |
| Total Shareholders Funds Annual | 1,621.46 | 1,438.58 | 1,284.28 |
| Total Assets Annual | 2,296.91 | 1,976.37 | 1,826.83 |
| Particulars | Mar 2024 |
|---|---|
| Fixed Assets Annual | 1,011.75 |
| Total Current Assets Annual | 1,134.06 |
| Non Current Assets Annual | 1,162.85 |
| Total Shareholders Funds Annual | 1,621.46 |
| Total Assets Annual | 2,296.91 |
EPS (INR)
Expected
6.03
Reported
6.03
Surprise
0.00%
Jun 2024
EPS beaten by 0.00%
Mar 2024
EPS beaten by 0.00%
Dec 2023
EPS beaten by 0.00%
